FindTrial
Sign In

Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease

Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004231
Enrollment
24
Registered
2019-08-21
Start date
2019-08-19
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Soon Chun Hyang University Hospital Bucheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Dry eye patients from the outpatient department Patients with a topical hyaluronic acid and supplemented with oral hyaluronic acid

Exclusion criteria

Exclusion criteria: less than 3 times visit during the study period imcomplete medical records regarding dry eye symptoms.

Design outcomes

Primary

MeasureTime frame
OSDI (ocular surface disease index)—

Secondary

MeasureTime frame
schirmer test, tear film break up time, corenal fluorescein stain score—

Countries

Korea, Republic of

Contacts

Public ContactSun Young Jang

Soon Chun Hyang University Hospital Bucheon

ysyat01@naver.com+82-32-621-6718

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026